| QSAR study of isatin analogues as in vitro anti-cancer agents R Sabet, M Mohammadpour, A Sadeghi, A Fassihi European journal of medicinal chemistry 45 (3), 1113-1118, 2010 | 77 | 2010 |
| Wound healing by topical application of antioxidant iron chelators: kojic acid and deferiprone M Mohammadpour, M Behjati, A Sadeghi, A Fassihi International wound journal 10 (3), 260-264, 2013 | 74 | 2013 |
| Antioxidant properties of Aloe vera components: a DFT theoretical evaluation SM Reza Nazifi, MH Asgharshamsi, MM Dehkordi, KK Zborowski Free radical research 53 (8), 922-931, 2019 | 48 | 2019 |
| Density functional theory studies of the antioxidants—a review S Mahmoudi, MM Dehkordi, MH Asgarshamsi Journal of Molecular Modeling 27 (9), 271, 2021 | 47 | 2021 |
| Synthesis and antioxidant evaluation of some novel ortho-hydroxypyridine-4-one iron chelators M Mohammadpour, A Sadeghi, A Fassihi, L Saghaei, A Movahedian, ... Research in pharmaceutical sciences 7 (3), 171, 2012 | 43 | 2012 |
| Synthesis and evaluation of antioxidant activity of some novel hydroxypyridinone derivatives: a DFT approach for explanation of their radical scavenging activity A Fassihi, F Hasanzadeh, AM Attar, L Saghaie, M Mohammadpour Research in pharmaceutical sciences 15 (6), 515-528, 2020 | 22 | 2020 |
| Theoretical study on the molecular tautomerism of the 3-hydroxy-pyridin-4-one system KK Zborowski, M Mohammadpour, A Sadeghi, LM Proniewicz Molecular Physics 111 (8), 958-967, 2013 | 11 | 2013 |
| Comparative modeling of CCRL1, a key protein in masked immune diseases and virtual screening for finding inhibitor of this protein M Behjati, I Torktaz, M Mohammadpour, G Ahmadian, AJ Easton Bioinformation 8 (7), 336, 2012 | 10 | 2012 |
| A Comparative DFT Study on the Antioxidant Activity of Some Novel 3‐Hydroxypyridine‐4‐One Derivatives MM Dehkordi, MH Asgarshamsi, A Fassihi, KK Zborowski Chemistry & Biodiversity 19 (3), e202100703, 2022 | 9 | 2022 |
| Theoretical studies of 1,4-dihydropyridine-3,5-dicarboxamides as possible inhibitors of Mycobacterium tuberculosis enoyl reductase K Mahnam, A Sadeghi, M Mohammadpour, A Fassihi Monatshefte für Chemie-Chemical Monthly 143, 19-27, 2012 | 9 | 2012 |
| The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects S Mahmoudi, MM Dehkordi, MH Asgarshamsi Biophysical Chemistry 288, 106824, 2022 | 7 | 2022 |
| Modeling of stability and properties of anionic and cationic tautomers of the 3-hydroxypyridin-4-one system M Mohammadpour, KK Zborowski, S Heidarpoor, G Żuchowski, ... Computational and Theoretical Chemistry 1078, 96-103, 2016 | 7 | 2016 |
| Design, Synthesis, Molecular Docking, and Molecular Dynamics Simulation Studies of Novel 3‐Hydroxypyridine‐4‐one Derivatives as Potential Acetylcholinesterase Inhibitors MH Asgarshamsi, A Fassihi, MM Dehkordi Chemistry & Biodiversity 20 (7), e202300325, 2023 | 2 | 2023 |
| Synthesis of Some Benzothiazole Derivatives Based on 3‐Hydroxypyridine‐4‐one and Benzaldehyde and Evaluation of Their β‐Amyloid Aggregation Inhibition Using both Experimental … MH Asgarshamsi, MM Dehkordi, HM Beigi, A Fassihi, L Saghaie Chemistry & Biodiversity 20 (10), e202301113, 2023 | 1 | 2023 |
| Theoretical evaluation of oleocanthal reactive centers MH Asgarshamsi, MM Dehkordi, SM Reza Nazifi, KK Zborowski Current Drug Metabolism 24 (11), 756-762, 2023 | | 2023 |
| Cardioprotection potential of some hydroxypyridine iron chelators against H2O2-induced H9C2 cell injury M Behjati, A Fassihi, MM Dehkordi, M Keshvari Turkiye Klinikleri Cardiovascular Sciences 29 (1), 10-16, 2017 | | 2017 |
Afshin FassihiProfessor of Medicinal Chemistry, Isfahan University在 pharm.mui.ac.ir 的电子邮件经过验证
